Desoxybenzoine 2-Phenylacetophenone Powder CAS 451-40-1 Raw Material

CAS: 638-94-8

MF: C24H32O6

MW: 416.51

EINECS: 211-351-6

Specification​: 99% min Desonide 

Sample: Desonide Powder

Brand: Henrikang

Appearance: White Powder

Storage: Cool Dry Place

Shelf Life: 2 Years

Test Method: HPLC

Portal:https://henrikang.en.made-in-china.com/

Desonide Powder Usage and Synthesis.

Desonide, English name Desonide, is a corticosteroid with strong anti-inflammatory effects.

Desonide Powder is a glucocorticoid with anti-inflammatory, anti-allergic, anti-itching and reduced oozing effects; it can attenuate and prevent the tissue's response to inflammation, Desonide Raw Material Material. tissue's response to inflammation, Desonide Raw Material can eliminate local non-infectious inflammation Desonide Raw Material can eliminate local non-infectious inflammation caused by inflammation. Desonide Raw Material can eliminate local non-infectious inflammation caused by fever, redness and swelling, thus reducing the manifestation of inflammation.

Desonide Raw Material has an immunosuppressive effect of preventing or inhibiting cellular immune response and suppressing the initial immune response. response.

Uses and functions of Desonide Powder.

Desonide Raw Material has an immunosuppressive effect of preventing or inhibiting cellular immune response and suppressing the initial immune response.Desonide is a low potency topical corticosteroid. Desonide is a low-potency topical corticosteroid hormone.

Desonide, the name of a Western drug. Commonly used dosage forms are creams or ointments. It is a glucocorticoid. It is used to relieve skin inflammation and itching caused by a variety of skin diseases that are sensitive to glucocorticoid therapy, and for the treatment of atopic dermatitis of 3 months or more.

Pharmacological Effects of Desonide Powder.

It is a topical glucocorticoid with anti-inflammatory, anti-allergic, antipruritic and ooze-reducing properties.

It is absorbed through normal and affected skin. The extent of percutaneous absorption is influenced by many factors, including drug composition and the integrity of the epidermal barrier. Skin encapsulation, inflammation or other diseases may increase percutaneous absorption.

Following dermal absorption, the pharmacokinetic pathway of the product is similar to that of systemically administered glucocorticoids. The plasma protein binding of this product varies widely among individuals. It is mainly metabolised in the liver and excreted via the kidneys and to a lesser extent via the bile.

Production method of Desonide Powder.